Navigation Links
CDC Recommends Flocked Swabs and Copan-Manufactured Viral Transport Media for Collection of H1N1 (Swine Flu) Virus
Date:5/5/2009

MURRIETA, Calif., May 5 /PRNewswire/ -- As of May 5, 2009, the World Health Organization, has officially reported 1124 cases of Influenza A (H1N1) infection in 21 different countries. As the situation with the novel H1N1 (Swine Flu) virus continues to evolve, the Centers for Disease Control and Prevention (CDC) continue to update their document Interim Guidance on Specimen Collection and Processing for Patients with Suspected Influenza A (H1N1) Virus. The objective of this document is to provide guidance on appropriate specimen collection, storage, processing, and testing for patients with suspected swine-origin influenza A (H1N1) virus infection.

One of the most widely used methods for detection of H1N1 flu virus is to collect a nasopharyngeal swab sample. The CDC recommends the use of synthetic tip swabs, such as Flocked Swabs, which exhibit a superior recovery of viruses. Several independent scientific studies published in the Journal of Clinical Microbiology and presented at Clinical Virology Symposium show that the quality of the sample taken using Copan Flocked Swabs is comparable to the quality of a sample collected from a nasopharyngeal aspirate or nasal was, which are considered the gold standard for upper respiratory virus samples. The open structure of Copan Flocked Swabs acts like a soft brush that efficiently dislodges and collects cells and mucus, then releases the sample immediately when put in a viral transport medium. In Ontario, the Agency for Health Protection and Promotion also lists Flocked Swabs as the preferred type of swab for respiratory virus sample collection on its latest version of LABstract on H1N1 Flu Virus (human swine influenza), Updated Guidance for Laboratory Testing, Hospital Setting. Copan Flocked Swabs are easy to use, are less invasive and cause minimal discomfort for the patient. Copan holds a worldwide patent on Flocked Swabs.

To transport H1N1 viral specimens collected usin
'/>"/>

SOURCE Copan Diagnostics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

6

GOOD

Page: 1 2

Related medicine news :

1. Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting
2. FDA Panel Recommends Approval of SyntheMeds REPEL-CV(R) Adhesion Barrier for Pediatric Patients
3. American College of Physicians recommends flu vaccination for health-care workers
4. ISS Recommends Hologic Stockholders Vote FOR Merger With Cytyc
5. FDA Panel Recommends Ban on Cold Medicines for Kids
6. AHRQ Report Recommends Use of Existing Call Centers to Expand Communications in Public Health Emergencies
7. National Association of EMS Educators (NAEMSE) Recommends Screening for Carbon Monoxide Poisoning
8. FDA Advisory Committee Recommends Approval of Abbotts XIENCE(TM) V Drug Eluting Stent System
9. Datascope Recommends Shareholders Re-Elect its Two Incumbent Directors and Reject Ramius Opposition Slate
10. FDA Advisory Committee Recommends Approval of KYNAPID(TM) for Acute Atrial Fibrillation
11. Senate Finance Committee Recommends Ways That Medicare Can Enhance Current Physician Quality Reporting Initiative (PQRI)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...s in animals , , MONDAY, Nov. 30 (Heal...that stem cells from transplanted human-derived um...heart disorders. , Scientists already know tha...st of different kinds of cells in the laboratory, ... Seoul, Korea, co-author of one of the studies, sa...
(Date:11/30/2009)...wire/ -- Kemin Foods, L.C. ("Kemin") and OmniActiv...Technologies, Ltd. ("OmniActive") have reached an ...agree that Kemin,s US Patent No. 5,382,714 ("the ,...cation and Recrystallization of Lutein from Saponi...reissues of that patent are valid and enforceable....
(Date:11/30/2009)...PRNewswire/ -- During this time of year, people be...oved one with Alzheimer,s disease or other form of...truggle with appropriate gift items. ,, Brookd...f senior living residences in the nation, includin...ggestions. ,, A listening device with recordin...
(Date:11/30/2009)... and Europa Uomo, the European,advocacy movement ...d into an,affiliated partnership as part of their...ient awareness in Europe with regards to urologica...ecretary-General of the EAU: "Thanks to this uniqu...in access to the latest information on,optimum su...
(Date:11/30/2009)...ched a series of clinical trials in order to asses... approach involves the application of personalised...rom the patient him or herself and designed to com...frequent malignant tumours. The new therapy is adm...the standard, first-line treatment involving surgi...
Breaking Medicine News(10 mins):Health News:Gift Ideas for Loved Ones with Alzheimer's/Dementia 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 3Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 4Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 5Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 6
...y hospital's inability to activate emergency power...ddle of a cataract surgery was awarded over Rs one... "It had taken about 15-20 minutes of crucial ...," observed the Consumer Disputes Redressal Forum ...
..., spread of infectious disease and food security u...ry in order to acquire the proper balance between ...phy professor of Kansas State University has used ...in uses remote sensing, in combination with other ...
...Toronto General Hospital, researchers have discove...ion //of specific repair cells from the bone marro...le it has long been known that bone marrow cells h... stem cells in repairing a damaged heart, restorin...
...a good 14 years has revealed that regular exercise...e body weight has an impact in cutting down the ri...uthor of the study, said "Even though erectile pro...." Obesity also affects sexual health, he said. ...
...f BARACLUDE? (entecavir) for the treatment of chro...proval by the Drug Controller General of India. ...atment of chronic hepatitis B virus infection in a... active disease. BARACLUDE? is an oral antiv...
...management training center, not only training Indi...tries//. The MV Hospital for Diabetes and Diabetes...zation’s collaborating centre for diabetes researc...e center is currently coaching a Pakistani physici...
Other Medicine News:Health News:Ecological Changes affects human health, food security 2Health News:Bone Marrow Cells Aid In Heart Repair 2Health News:Bone Marrow Cells Aid In Heart Repair 3Health News:India Approves Baraclude? (entecavir) For ,Treatment Of Chronic HEPATITIS B 2
(Date:11/30/2009).../ -- Reportlinker.com announces that a new market ..., Inflammatory Disorders: Therapies That Suppres...w.reportlinker.com/p0165600/Inflammatory-Disorders...ponse.html ,, The human immune system can go a...ing an exaggerated response to a foreign substance...
(Date:11/30/2009)... Jocelyn Rapelyea, Associate Director of Breast Im...sity Medical Center in Washington, D.C., demonstra...ific Gamma Imaging (BSGI) can be localized utilizi...l, as for pre-operative localization today at the ...h America (RSNA). ,, BSGI was conducted using a...
(Date:11/30/2009)...- Minimally-invasive procedures are increasingly r... oncology, cardiology and women,s health applicati...tion expected to reach $600 million by 2015, clini...mally-invasive procedures, including shorter patie...ter patient throughput. ,, (Logo: http://www...
Breaking Medicine Technology:Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 2Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 3Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 4Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 5Breast-Specific Gamma Imaging Identifies Occult Lesions Using Multi-Modality Imaging for Biopsy 2Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 2Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 3Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 4Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 5Lexington Health Care Names New Chief Executive Officer 51899 1Lexington Health Care Names New Chief Executive Officer 51899 2Technology Collaborative Launches Online Game to Exercise Brain Power of People with Multiple Sclerosis 51897 1Technology Collaborative Launches Online Game to Exercise Brain Power of People with Multiple Sclerosis 51897 2Technology Collaborative Launches Online Game to Exercise Brain Power of People with Multiple Sclerosis 51897 3Technology Collaborative Launches Online Game to Exercise Brain Power of People with Multiple Sclerosis 51897 4PAL Health Technologies Wins State Level Prestigious Employer of the Year Award 51895 1PAL Health Technologies Wins State Level Prestigious Employer of the Year Award 51895 2
...ults of Roche and Ipsen,s First Once-Weekly Human ...iation Meeting -, NUTLEY, N.J., June 10 Roche an...poglutide (R1583) has been shown to provide,signif...oss after only,eight weeks of treatment(1,2) with ...try into Phase III. Taspoglutide, originating from...
...estigational Diabetes Therapy Also Improved Glucos... Taken Twice a Day, SAN FRANCISCO, June 9 Amylin...and Company (NYSE: LLY ), and Alkermes, Inc.,(Nas...k open-label clinical,study that showed the durabl... release formulation of exenatide. Patients taking...
Other Medicine Technology:Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 2Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 3Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 4Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 5Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials 6After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 2After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 3After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 4After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 5After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 6After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 7After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 8After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 9
Cushing Burr
Doro J-Arm Retractor System
Molt 9
Langenbeck Periosteal Elevators
Medicine Products: